36
Views
26
CrossRef citations to date
0
Altmetric
Original Research

RETRACTED ARTICLE: In vitro/vivo drug release and anti-diabetic cardiomyopathy properties of curcumin/PBLG-PEG-PBLG nanoparticles

, , &
Pages 1945-1962 | Published online: 03 Apr 2018
 

Abstract

Tong F, Chai R, Jiang H, Dong B. Int J Nanomedicine. 2018;13:1945—1962.

At the request of the authors, the Editor and Publisher of International Journal of Nanomedicine wish to retract the published article. We were notified by the authors of potential issues relating to the reliability of the data in the published article. Specifically:

  • Figure 5A panel a (Sham group) appears to be duplicated with Figure 5A panel b (DM-4w group).

  • Figure 7A panel g (Curcumin+CaRI group) appears to be duplicated with Figure 7A panel h (Curcumin/P+CaRI group).

  • Figure 7F panel a (Sham group) appears to be duplicated with Figure 7F panel e (Curcumin+CaRS group).

  • Figure 7F panel d (Curcumin/P group) appears to be duplicated with Figure 7F panel f (Curcumin/P+CaRS group).

  • Figure 8A panel g (Curcumin+CaRS+PAG group) appears to be duplicated with Figure 8A panel h (Curcumin/P+CaRS+PAG group).

  • Figure 9A panels b and e appear to show repeated elements.

  • Figure 9B panels b, e and f appear to show repeated elements.

The authors explained mistakes were made due to carelessness during the preparation of the figures which led to the duplicated images. The authors requested for the article to be retracted and wish to apologise for this error.

Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.

View retraction statement:
In vitro/vivo Drug Release and Anti-Diabetic Cardiomyopathy Properties of Curcumin/PBLG-PEG-PBLG Nanoparticles [Retraction]